Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
MARKHAM, Ontario, April 19, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to be voted upon at its annual and special meeting of shareholders held on April 19, 2022 (the "Meeting"). In particular, all nominees listed in the Company's information circular dated March 4, 2022 were elected as directors of the Company. The proxy voting results for each nominee are as follows:
Nominee
Votes For
Votes Withheld
No.
%
No.
%
Paul Boniferro
20,201,117
99.28
147,416
0.72
Dino Chiesa
18,916,541
92.96
1,431,992
7.04
Nitin Jain
20,156,475
99.06
192,058
0.94
Shelly Jamieson
20,093,945
98.75
254,588
1.25
Brian Johnston
17,611,964
86.55
2,736,569
13.45
Paula Jourdain Coleman
19,639,031
96.51
709,502
3.49
Stephen Sender
19,269,345
94.70
1,079,188
5.30
Proxy voting results for all matters voted on at the Meeting will be filed on SEDAR at www.sedar.com.
ABOUT SIENNA SENIOR LIVING
Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors' living options, including independent living, assisted living, long-term care, and specialized programs and services. Sienna's approximately 12,000 employees are passionate about helping residents live fully every day. For more information, please visit www.siennaliving.ca.
FOR FURTHER INFORMATION PLEASE CONTACT:
David Hung Chief Financial Officer and Executive Vice President (905) 489-0254 [email protected]
Nancy Webb Senior Vice President, Public Affairs and Marketing (905) 489-0788 [email protected]
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.
The...
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident.
What Happened?
On March 5, 2024, AD detected it was the...
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...